Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Adamson

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Pediatric Blood & Cancer|November 20, 2013
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group StudyRochelle Bagatell, Robin Norris, Ashish M Ingle, et al.
Cancer|May 13, 2004
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcomaBrigitte C Widemann, Frank M Balis, Beate Kempf-Bielack, et al.
Journal of Clinical Pharmacology|December 21, 2007
Population pharmacokinetic investigation of actinomycin-D in children and young adultsJohn T Mondick, Leonid Gibiansky, Marc R Gastonguay, et al.
The Oncologist|July 1, 2008
Characteristics and outcome of pediatric patients enrolled in phase I oncology trialsAerang Kim, Elizabeth Fox, Katherine Warren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2010
Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group reportJack M Su, Xiao-Nan Li, Patrick Thompson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2007
Recommended changes to oncology clinical trial design: revolution or evolution?Mark J Ratain, Rachel W Humphrey, Gary B Gordon, et al.
Neuro-Oncology|May 24, 2008
A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhoodRegina I Jakacki, Allan Yates, Susan M Blaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortiumRichard Aplenc, Susan M Blaney, Lewis C Strauss, et al.
The Pediatric Infectious Disease Journal|July 14, 2009
Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infantsKelly C Wade, Daniel K Benjamin, David A Kaufman, et al.
Pediatric Blood & Cancer|August 20, 2013
Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology GroupBrenda Weigel, Suman Malempati, Joel M Reid, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Pediatric Blood & Cancer|November 20, 2013
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group StudyRochelle Bagatell, Robin Norris, Ashish M Ingle, et al.
Cancer|May 13, 2004
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcomaBrigitte C Widemann, Frank M Balis, Beate Kempf-Bielack, et al.
Journal of Clinical Pharmacology|December 21, 2007
Population pharmacokinetic investigation of actinomycin-D in children and young adultsJohn T Mondick, Leonid Gibiansky, Marc R Gastonguay, et al.
The Oncologist|July 1, 2008
Characteristics and outcome of pediatric patients enrolled in phase I oncology trialsAerang Kim, Elizabeth Fox, Katherine Warren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2010
Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group reportJack M Su, Xiao-Nan Li, Patrick Thompson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2007
Recommended changes to oncology clinical trial design: revolution or evolution?Mark J Ratain, Rachel W Humphrey, Gary B Gordon, et al.
Neuro-Oncology|May 24, 2008
A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhoodRegina I Jakacki, Allan Yates, Susan M Blaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortiumRichard Aplenc, Susan M Blaney, Lewis C Strauss, et al.
The Pediatric Infectious Disease Journal|July 14, 2009
Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infantsKelly C Wade, Daniel K Benjamin, David A Kaufman, et al.
Pediatric Blood & Cancer|August 20, 2013
Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology GroupBrenda Weigel, Suman Malempati, Joel M Reid, et al.
Pageof 18